Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Murphy

Showing results (731-740 of 751) with videos related to

Pageof 76
Sort By:
Journal of Surgical Oncology|August 1, 1997
Cloning, sequence, and developmental expression analysis of C4-2, a potential brain tumor-suppressor geneA Sehgal, S Ricks, C Keener, et al.
Cancer|April 15, 1980
Chemotherapy programs of the National Prostatic Cancer Project (NPCP)J D Schmidt, W W Scott, R Gibbons, et al.
The Journal of Urology|August 1, 1977
A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiationG P Murphy, R P Gibbons, D E Johnson, et al.
The Prostate|April 1, 1996
Measurement of prostate-specific membrane antigen in the serum with a new antibodyG P Murphy, W T Tino, E H Holmes, et al.
Journal of the National Cancer Institute|January 1, 1982
Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigensM Kuriyama, M C Wang, C L Lee, et al.
The Journal of Urology|February 1, 1979
Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostateJ D Schmidt, W W Scott, R P Gibbons, et al.
Transactions of the American Association of Genito-Urinary Surgeons|January 1, 1978
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiationG P Murphy, R P Gibbons, D E Johnson, et al.
The Prostate|July 3, 1998
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptidesB A Tjoa, S J Simmons, V A Bowes, et al.
The Journal of Urology|June 1, 1979
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiationG P Murphy, R P Gibbons, D E Johnson, et al.
Urology|June 4, 1998
Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancerG P Murphy, G M Kenny, H Ragde, et al.
Pageof 76

Showing results (731-740 of 751) with videos related to

Sort By:
Pageof 76
Journal of Surgical Oncology|August 1, 1997
Cloning, sequence, and developmental expression analysis of C4-2, a potential brain tumor-suppressor geneA Sehgal, S Ricks, C Keener, et al.
Cancer|April 15, 1980
Chemotherapy programs of the National Prostatic Cancer Project (NPCP)J D Schmidt, W W Scott, R Gibbons, et al.
The Journal of Urology|August 1, 1977
A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiationG P Murphy, R P Gibbons, D E Johnson, et al.
The Prostate|April 1, 1996
Measurement of prostate-specific membrane antigen in the serum with a new antibodyG P Murphy, W T Tino, E H Holmes, et al.
Journal of the National Cancer Institute|January 1, 1982
Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigensM Kuriyama, M C Wang, C L Lee, et al.
The Journal of Urology|February 1, 1979
Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostateJ D Schmidt, W W Scott, R P Gibbons, et al.
Transactions of the American Association of Genito-Urinary Surgeons|January 1, 1978
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiationG P Murphy, R P Gibbons, D E Johnson, et al.
The Prostate|July 3, 1998
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptidesB A Tjoa, S J Simmons, V A Bowes, et al.
The Journal of Urology|June 1, 1979
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiationG P Murphy, R P Gibbons, D E Johnson, et al.
Urology|June 4, 1998
Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancerG P Murphy, G M Kenny, H Ragde, et al.
Pageof 76